Drug Information Association Logo
Corporate Tagline

Medical Writing: Clinical Overview

Mar 18 2013 1:30PM - Mar 18 2013 5:00PM | Sheraton Wild Horse Pass Resort & Spa 5594 West Wild Horse Pass Boulevard Chandler, AZ 85226

« Back to Listing

Overview 

This course provides an in-depth analysis of the preparation of a Clinical Overview for pharmaceutical products (drugs and biologics) in accordance with ICH guidelines concerning development of Module 2.5 of a Common Technical Document (CTD).

  • The objectives, structure, and format of the Clinical Overview is explored, with attention given to developing a document suitable for multi-region submissions.
  • The inclusion and presentation of clinical and nonclinical data are discussed in detail, with emphasis on how to effectively use the other technical summaries within the CTD.
  • Insight is provided on how to prepare a document that successfully communicates the benefits and risks of the investigational product.
  • Specific examples are provided regarding how to frame the different sections of the Clinical Overview to best communicate the product’s unique attributes.
  • While the course emphasis is on developing the Clinical Overview for a new chemical entity, insight in to developing the Clinical Overview for other type of submissions will be provided.

Learning Objectives 

At the conclusion of this tutorial, participants should be able to:

  • Communicate the role of a Clinical Overview (Module 2.5) in a CTD
  • Describe the structure and format of a Clinical Overview in accordance with ICH guidelines
  • Develop strategies regarding the placement and presentation of information different sections of the Clinical Overview
  • Explain how to effectively cross-reference to other components of the CTD
  • Develop a submission-ready Clinical Overview that successfully communicates all available information concerning the benefits and risks of an investigational product
  • Recognize how to modify the Clinical Overview for different submission types

Instructor(s) 

Previous Next

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

Participants with Disabilities:
Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

« Back to Listing Back To Top